Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study.
Rendle KA, Saia CA, Vachani A, Burnett-Hartman AN, Doria-Rose VP, Beucker S, Neslund-Dudas C, Oshiro C, Kim RY, Elston-Lafata J, Honda SA, Ritzwoller D, Wainwright JV, Mitra N, Greenlee RT. Rendle KA, et al. Among authors: doria rose vp. Ann Intern Med. 2024 Jan;177(1):18-28. doi: 10.7326/M23-0653. Epub 2024 Jan 2. Ann Intern Med. 2024. PMID: 38163370
Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds.
Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Burnett-Hartman AN, Corley DA, Doria-Rose VP, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J. Dalmat RR, et al. Among authors: doria rose vp. Cancer Epidemiol Biomarkers Prev. 2023 Oct 2;32(10):1382-1390. doi: 10.1158/1055-9965.EPI-23-0265. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 37450838 Free PMC article.
Test performance metrics for breast, cervical, colon, and lung cancer screening: a systematic review.
Selby K, Sedki M, Levine E, Kamineni A, Green BB, Vachani A, Haas JS, Ritzwoller DP, Croswell JM, Ohikere K, Doria-Rose VP, Rendle KA, Chubak J, Lafata JE, Inadomi J, Corley DA. Selby K, et al. Among authors: doria rose vp. J Natl Cancer Inst. 2023 Apr 11;115(4):375-384. doi: 10.1093/jnci/djad028. J Natl Cancer Inst. 2023. PMID: 36752508 Free PMC article.
Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study.
Silvestri GA, Goldman L, Burleson J, Gould M, Kazerooni EA, Mazzone PJ, Rivera MP, Doria-Rose VP, Rosenthal LS, Simanowith M, Smith RA, Tanner NT, Fedewa S. Silvestri GA, et al. Among authors: doria rose vp. Ann Intern Med. 2022 Nov;175(11):1501-1505. doi: 10.7326/M22-1325. Epub 2022 Oct 11. Ann Intern Med. 2022. PMID: 36215712
Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines.
Kamineni A, Doria-Rose VP, Chubak J, Inadomi JM, Corley DA, Haas JS, Kobrin SC, Winer RL, Elston Lafata J, Beaber EF, Yudkin JS, Zheng Y, Skinner CS, Schottinger JE, Ritzwoller DP, Croswell JM, Burnett-Hartman AN. Kamineni A, et al. Among authors: doria rose vp. Ann Intern Med. 2022 Nov;175(11):1582-1590. doi: 10.7326/M22-1139. Epub 2022 Sep 27. Ann Intern Med. 2022. PMID: 36162112 Free PMC article. Review.
Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.
Beaber EF, Kamineni A, Burnett-Hartman AN, Hixon B, Kobrin SC, Li CI, Oliver M, Rendle KA, Skinner CS, Todd K, Zheng Y, Ziebell RA, Breslau ES, Chubak J, Corley DA, Greenlee RT, Haas JS, Halm EA, Honda S, Neslund-Dudas C, Ritzwoller DP, Schottinger JE, Tiro JA, Vachani A, Doria-Rose VP. Beaber EF, et al. Among authors: doria rose vp. Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1521-1531. doi: 10.1158/1055-9965.EPI-22-0100. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35916603 Free PMC article.
74 results